top of page

Specializing in Breakthrough Research

Excellence, Innovation, and Tailored Solutions in Infectious Disease, Ultra Rare, Rare Disease, and Chronic Condition Research.


Rubix LS is focusing on supporting the design, launch, and execution of Phase I - Phase III trials (Phase IV coming in 2024) for patients in underserved and underrepresented communities.

Rubix LS stands at the forefront of contract research with a specialized focus on infectious diseases, ultrarare rare diseases, and chronic condition research. Our commitment is to deliver outstanding research support infused with expertise and innovation, from initial concept to commercialization. We ensure quality, compliance, and efficiency at every stage of your research project.

Our services for complex challenges

Pre-clinical research in specialized areas

  • PK/PD Studies: Our preclinical services include in-depth Pharmacokinetics (PK) and Pharmacodynamics (PD) studies, crucial for understanding the absorption, distribution, metabolism, excretion (ADME), and therapeutic effects of potential drug candidates. This essential analysis informs dosing, efficacy, and safety profiles, guiding the progression to clinical trials.

  • Focused Study Design: We develop specialized study designs for Infectious Disease, Ultra Rare, Rare Disease, and Chronic Conditions, leveraging our extensive expertise to address the unique challenges of these areas.

Clinical trial management: from patients to progress

  • Ethical and Representative Recruitment: Specializing in patient recruitment for challenging populations, we ensure ethical and effective clinical trials in specialized disease areas.

  • Regulatory Adherence: Our team excels in navigating the complex regulatory landscapes specific to Infectious Disease, Ultra Rare, and Rare Disease research.

Bioinformatics and Data Analysis: Unlocking Insights

  • Data-Driven Decisions: Utilizing sophisticated bioinformatics tools, we manage and analyze complex datasets, providing critical insights for your research.

  • AI Integration: Our AI capabilities enhance data interpretation, especially in intricate fields like Infectious Disease, Ultra Rare, and Rare Disease, and Chronic Conditions.

Read More >
Collaborating at Work

Customized Research Services for Your Unique Needs

Our approach is to customize each project to your specific research goals. We cater to a diverse range of clients, from emerging biotech startups to established pharmaceutical companies, offering tailored strategies and dedicated support.

  • Strategic Planning for Specialized Research: Our strategies are crafted to address the unique challenges of Infectious Disease, Ultra Rare, and Rare Disease research.

  • Expert Teams for Focused Outcomes: Benefit from our team of seasoned professionals who bring specialized knowledge and experience in these disease areas.


  • Regulatory Consulting
  • Market Analysis
  • Strategic/Project Planning
  • Quality Assurance
  • Conceptual R&D Development
  • and more...
Reach out to a team member today to find out more information.

Collaborate with Rubix LS

Join forces with Rubix LS for contract research that transcends traditional boundaries. Our specialized focus in Infectious Disease, Ultra Rare, Rare Disease, and Chronic Conditions places us uniquely positioned to advance research in these critical areas.

Get in Touch: To explore our contract research services or discuss your specific project needs, please contact us at


60 Island St, Suite 236

Lawrence, MA 01840

Tel: 978-552-3183

Thanks for subscribing!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram
  • Whatsapp

© 2023 by Rubix LS.

bottom of page